These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24127779)

  • 41. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Menopausal hormone therapy, hormone receptor status, and lung cancer in women.
    Chlebowski RT
    Semin Oncol; 2009 Dec; 36(6):566-71. PubMed ID: 19995648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
    Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
    JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial.
    Vajaranant TS; Ray RM; Pasquale LR; Mares JA; Ritch R; Gower EW; Haan MN; Jackson RD; Maki PM
    Am J Ophthalmol; 2018 Nov; 195():110-120. PubMed ID: 30081016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
    Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
    Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
    Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
    Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of WHI conclusions and ACOG guidelines on clinical practice.
    Gass M
    Int J Fertil Womens Med; 2003; 48(3):106-10; discussion 137-8. PubMed ID: 12839140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast.
    Luo J; Cochrane BB; Wactawski-Wende J; Hunt JR; Ockene JK; Margolis KL
    Breast Cancer Res Treat; 2013 Feb; 137(3):915-25. PubMed ID: 23315265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
    Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
    Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial.
    Brunner RL; Gass M; Aragaki A; Hays J; Granek I; Woods N; Mason E; Brzyski R; Ockene J; Assaf A; LaCroix A; Matthews K; Wallace R;
    Arch Intern Med; 2005 Sep; 165(17):1976-86. PubMed ID: 16186467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials.
    Crandall CJ; Aragaki AK; Cauley JA; McTiernan A; Manson JE; Anderson G; Chlebowski RT
    Breast Cancer Res Treat; 2012 Feb; 132(1):275-85. PubMed ID: 22042371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The WHI ten year's later: an epidemiologist's view.
    Lacey JV
    J Steroid Biochem Mol Biol; 2014 Jul; 142():12-5. PubMed ID: 24029430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
    Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: Findings from the Women's Health Initiative.
    Al-Rousan T; Sparks JA; Pettinger M; Chlebowski R; Manson JE; Kauntiz AM; Wallace R
    PLoS One; 2018; 13(12):e0207509. PubMed ID: 30513095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invited commentary: Postmenopausal unopposed estrogen and breast cancer risk in the Women's Health Initiative--before and beyond.
    Linet MS
    Am J Epidemiol; 2008 Jun; 167(12):1416-20. PubMed ID: 18448443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.
    Watts NB; Cauley JA; Jackson RD; LaCroix AZ; Lewis CE; Manson JE; Neuner JM; Phillips LS; Stefanick ML; Wactawski-Wende J; Crandall C;
    J Clin Endocrinol Metab; 2017 Jan; 102(1):302-308. PubMed ID: 27820659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM; Henderson VW
    Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study.
    Haan MN; Klein R; Klein BE; Deng Y; Blythe LK; Seddon JM; Musch DC; Kuller LH; Hyman LG; Wallace RB
    Arch Ophthalmol; 2006 Jul; 124(7):988-92. PubMed ID: 16832022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
    Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
    Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.